AR241650A1 - Procedimiento para obtener compuestos relacionados con la espergualina - Google Patents

Procedimiento para obtener compuestos relacionados con la espergualina

Info

Publication number
AR241650A1
AR241650A1 AR83294077A AR29407783A AR241650A1 AR 241650 A1 AR241650 A1 AR 241650A1 AR 83294077 A AR83294077 A AR 83294077A AR 29407783 A AR29407783 A AR 29407783A AR 241650 A1 AR241650 A1 AR 241650A1
Authority
AR
Argentina
Prior art keywords
ala
benzil
beta
formula
spergualin
Prior art date
Application number
AR83294077A
Other languages
English (en)
Original Assignee
Zh Biseibutsu Kagaku Kenkyukai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zh Biseibutsu Kagaku Kenkyukai filed Critical Zh Biseibutsu Kagaku Kenkyukai
Application granted granted Critical
Publication of AR241650A1 publication Critical patent/AR241650A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

OBTENCION DE COMPUESTOS RELACIONADOS CON LA ESPERGUALINA, DE FORMULA (I), DONDE R1 ES H, HIDROXILO, O ALCANOILOXI; R2 ES GLY, SERIL, ALA, BETA-ALA, GAMMA-AMILOBUTANOILO, PRO, LEU, ASN, GLU, ARG,NE, HIS, THREO O HOMOSERIL, Y M ES 4 A 6, ELIMINANDO LOS GRUPOS PROTECTORES POR REDUCCION, CON HIDROGENACION CATALITICA, HIDROLISIS, POR DESCOMPOSICION EN MEDIO ACIDO O CON HIDRAZINA, EN UN COMPUESTO DE FORMULA (II). DONDE R2 ES GLY, -O- BENZILSERIL, -O-TERT-BUTILSERIL, ALA, BETA-ALA, GAMMA-AMINOBUTANOILO, PRO, LEU, BETA-BENZIL-ASN, GLU, N-NITRO-ARG, PHE, 3-N-BENZIL-HIS, -O-BENZIL- THREO OHOMOSERIL Y R3 Y R4 SON UN GRUPO DE FORMULA: (III), (IV), (V), (VI), (VII), (VIII), (IX),(X), (XI) Y (XII).
AR83294077A 1982-09-02 1983-08-31 Procedimiento para obtener compuestos relacionados con la espergualina AR241650A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57151698A JPS5942356A (ja) 1982-09-02 1982-09-02 スパガリン関連化合物およびその製造法

Publications (1)

Publication Number Publication Date
AR241650A1 true AR241650A1 (es) 1992-10-30

Family

ID=15524303

Family Applications (1)

Application Number Title Priority Date Filing Date
AR83294077A AR241650A1 (es) 1982-09-02 1983-08-31 Procedimiento para obtener compuestos relacionados con la espergualina

Country Status (14)

Country Link
US (1) US4529549A (es)
EP (1) EP0105193B1 (es)
JP (1) JPS5942356A (es)
KR (1) KR900008137B1 (es)
AR (1) AR241650A1 (es)
AT (1) ATE36701T1 (es)
AU (1) AU560073B2 (es)
CA (1) CA1199641A (es)
CS (1) CS235341B2 (es)
DE (1) DE3377795D1 (es)
DK (1) DK160089C (es)
ES (1) ES8506267A1 (es)
HU (1) HU190730B (es)
MX (1) MX8257A (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5862152A (ja) * 1981-10-08 1983-04-13 Microbial Chem Res Found Ｎ−〔４−（３−アミノプロピル）アミノブチル〕−２−（ω−グアニジノ脂肪酸アミド）−２−ヒドロキシエタンアミドおよびその誘導体ならびにその製造法
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤
JPS61165322A (ja) * 1985-01-14 1986-07-26 Microbial Chem Res Found スパガリン類の注射用凍結乾燥製剤
JPH075538B2 (ja) * 1985-08-27 1995-01-25 財団法人微生物化学研究会 フエニレン基を有するスパガリン関連ニトリル化合物及びその製造法
EP0241797B1 (en) * 1986-04-04 1991-06-12 Microbial Chemistry Research Foundation Novel spergualin-related compounds and process for producing the same
EP0284632A1 (en) * 1987-03-30 1988-10-05 Shosuke Okamoto Phenylalanine derivative and proteinase inhibitor
JPH0794424B2 (ja) * 1987-09-30 1995-10-11 財団法人微生物化学研究会 新スパガリン関連化合物およびその製造法
US5061787A (en) * 1988-06-24 1991-10-29 Nippon Kayaku Kabushiki Kaisha Novel spergualin-related compounds and compositions
JPH0776204B2 (ja) * 1988-07-01 1995-08-16 寳酒造株式会社 スパガリン類の精製法
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
EP0467280B1 (en) * 1990-07-20 1994-09-28 Nippon Kayaku Kabushiki Kaisha Novel spergualin-related compound and use thereof
WO1994004140A1 (en) * 1992-08-19 1994-03-03 Nippon Kayaku Kabushiki Kaisha Antiprotozoan drug
FR2698628B1 (fr) * 1992-12-02 1995-02-17 Fournier Ind & Sante Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2716451B1 (fr) * 1994-02-24 1996-04-26 Fournier Ind & Sante Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2716452B1 (fr) * 1994-02-24 1996-05-10 Fournier Ind & Sante Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2737891B1 (fr) * 1995-08-17 1997-10-24 Fournier Ind & Sante Analogues chiraux de la 15-deoxyspergualine, procede de preparation et utilisation en therapeutique
DK0755380T3 (da) * 1995-02-10 1999-06-23 Fournier Ind & Sante 15-deoxyspergualin-analoge, deres terapeutiske anvendelse og fremgangsmåde til fremstilling deraf
FR2730488B1 (fr) * 1995-02-10 1997-04-30 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur utilisation en therapeutique et leur procede de preparation
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3737443A (en) * 1969-04-02 1973-06-05 Taiho Pharmaceutical Co Ltd Omega-guanidino acid amide derivatives and manufacturing the same
JPS507057B1 (es) * 1970-10-28 1975-03-20
US3937805A (en) * 1971-11-10 1976-02-10 Colgate-Palmolive Company Method of making dentifrice compositions containing insolubilized salts of 1,6-di-(p-chlorophenyl biguanido) hexane
JPS5748957A (en) * 1980-09-08 1982-03-20 Microbial Chem Res Found Novel antibiotic bmg 162-af2, its preparation and carcinostatic agent comprising it as active ingredient
CH648289A5 (de) * 1981-05-11 1985-03-15 Microbial Chem Res Found N-(4-(3-aminopropyl)-aminobutyl)-2,2-dihydroxyaethanamid und verfahren zu seiner synthese.

Also Published As

Publication number Publication date
DK160089C (da) 1991-06-24
KR840006332A (ko) 1984-11-29
HU190730B (en) 1986-10-28
DK398583A (da) 1984-03-03
CA1199641A (en) 1986-01-21
KR900008137B1 (ko) 1990-10-31
EP0105193A2 (en) 1984-04-11
DK160089B (da) 1991-01-28
AU1807483A (en) 1984-03-08
US4529549A (en) 1985-07-16
ES525278A0 (es) 1985-07-01
MX8257A (es) 1994-01-31
ES8506267A1 (es) 1985-07-01
EP0105193B1 (en) 1988-08-24
ATE36701T1 (de) 1988-09-15
JPS5942356A (ja) 1984-03-08
AU560073B2 (en) 1987-03-26
DE3377795D1 (en) 1988-09-29
JPH0149256B2 (es) 1989-10-24
DK398583D0 (da) 1983-09-01
CS235341B2 (en) 1985-05-15
EP0105193A3 (en) 1985-04-03

Similar Documents

Publication Publication Date Title
AR241650A1 (es) Procedimiento para obtener compuestos relacionados con la espergualina
ZA844585B (en) 2-pyrimidinyl-1-piperazine derivatives,processes for their preparation and medicaments containing them
HUT36784A (en) Process for producing spasmolytic sulfanate derivatives and pharmaceutical compositions containing them as active agents
FI810389L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
ES8601998A1 (es) Procedimiento de preparacion de derivados de 1,3-dihidro-6-metil-7-hidroxi-furo-(3,4-c)-piridina
DE69217873T2 (de) Verfahren zur Herstellung von 2-Chlor-2'-Desoxyadenosin
ES8203897A1 (es) Procedimiento para la obtencion de imidazoazoalquenamidas
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
JPS57106695A (en) Anthracycline g lycoside compound
DE3683822D1 (de) Chartreusinderivate und salze, diese enthaltende antitumorzusammensetzungen und verfahren zu ihrer herstellung.
DE3474298D1 (en) Derivatives of 4-phenyl-4-oxo-buten-2-oic acid, their preparation, medicaments and compositions containing them
ATE18226T1 (de) Pyrrolo(2,3-d)carbazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ES8609319A1 (es) Procedimiento de preparacion de nuevas fenil-naftiridinas.
ES8200689A1 (es) Un procedimiento para la produccion de analogos de cefalosporina.
ES8600768A1 (es) Imidazotiadiazolalquencarboxiamidas
ES8607971A1 (es) Procedimiento para la obtencion de compuestos de 2-heterociclil-tio-alquilo inferior-penem
ES8201986A1 (es) Un procedimiento para la preparacion de derivados de 1,2,4- triazolidin-3,5-diona
AR241490A1 (es) Procedimiento para preparar derivados de isoquinolina.
JPS574984A (en) Alpha-hydroxyalkylnorbornanone acetal and its preparation
ATE15669T1 (de) Derivate der 3-amino-1-heteroaryloxy-propanolklasse, ihre verwendung in der therapie und ein verfahren zu ihrer herstellung.
JPS5490190A (en) Preparation of optical isomer of alpha-amino-p-hydroxybenzylpenicillin
TH1916EX (th) สารประเภท 9-(1 หรือ 3-โมโนเอซิลอ๊อกซี หรือ 1,3-ไดเอซิลอ๊อกซี-2-โพรพ๊อกซีเมทธิล) พิวรีน ที่มีกลุ่มแทนที่ ซึ่งเป็นยาฆ่าเชื้อไวรัส
TH1556B (th) สารประกอบชนิดใหม่และสารผสมของสารนี้